Guo et al. [75] found an explanation that thepharmacological inhibition of prolyl hydroxylase reversed the impairment of HIF-1expression and activity in diabetes and obviously counteracted the suppression ofAAA enlargement by diabetes, with increased angiogenesis, leukocyte infiltration,and medial elastin and VSMCs destruction. The gene discussed is ELN; the disease is diabetes mellitus.